SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-24-021918
Filing Date
2024-02-01
Accepted
2024-02-01 16:49:43
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 d723101d424b5.htm 424B5 413580
2 GRAPHIC g723101g01p01.jpg GRAPHIC 44797
  Complete submission text file 0001193125-24-021918.txt   471915
Mailing Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339
Business Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339 678-392-3419
Inhibikase Therapeutics, Inc. (Filer) CIK: 0001750149 (see all company filings)

IRS No.: 263407249 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-262551 | Film No.: 24587659
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)